DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Mantovani A, Byrne CD, Targher G.
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review.
Lancet Gastroenterol Hepatol 2022:S2468-1253(21)00261-2
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.